COMMUNIQUÉS West-GlobeNewswire
-
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/10/2026 -
Monthly information on share capital and company voting rights
06/10/2026 -
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
06/10/2026 -
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
06/10/2026 -
Remix Therapeutics™ Appoints Michael Landsittel to Board of Directors
06/10/2026 -
Community HealthCare Resources Launches Fall 2026 Clinician Recruitment Initiative
06/10/2026 -
Ozari Health Launches Ozari One: Compounded Tirzepatide Online for $125 a Month, Same Price at Every Dose
06/10/2026 -
Going Beyond Addiction
06/10/2026 -
Fast Company Names Veyond Metaverse a 2026 Next Big Things in Tech Winner for OceanMD, XR Telemedicine for Ships and Remote Sites
06/10/2026 -
MedSpa Board and QUAD A Provide Joint Guidance on IV Infusion Safety Following Recent Safety Concerns
06/10/2026 -
Recognizing Warnings Before a Crisis
06/10/2026 -
Blink Anesthesia, maker of the TwitchView® quantitative neuromuscular monitor, names Medtronic veteran Lindsay Boyle VP of Commercial Operations
06/10/2026 -
Nox Peptides Announces Launch of BPC-157 Research Product and Resources for Canadian Research Market
06/10/2026 -
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
06/10/2026 -
RAMSAY SANTE : résultats annuels définitifs à fin juin 2026
06/10/2026 -
RAMSAY SANTE : Final annual results as of 30 June 2026
06/10/2026 -
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
06/10/2026 -
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
06/10/2026 -
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
06/10/2026
Pages